Riskpilot← Back to searchSign inGet full accessOrtofys Skane AB
ABActiveOrg 5590562616Mittlinjen 13 BPhysiotherapy activities · NACE 8695Est. 20161 employees
Revenue 2025
SEK 1,7M
+6% vs 2024
EBITDA margin
21.6%
+17% vs 2024
Equity ratio
16.0%
Financial strength
Net profit 2025
SEK 251K
+108% vs 2024
| Revenue | SEK 1,7M | +6% |
| EBITDA | SEK 359K | +17% |
| Net profit | SEK 251K | +108% |
| Total assets | SEK 1,9M | +4% |
| Equity | SEK 302K | -19% |
| Employees | 1 | — |
Legal name
Ortofys Skane AB
Org number
5590562616
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
23 mars 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva fysioterapi och därmed förenlig verksamhet.
Address
Mittlinjen 13 B
Email
rickard.ortofys@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 300 | 1 362 | 1 423 | 1 571 | 1 661 |
| Staff expenses | — | −864 | −938 | −957 | −985 |
| EBITDA | 195 | 308 | 229 | 306 | 359 |
| Depreciation & amort. | −18 | −18 | −19 | −26 | −26 |
| EBIT | 177 | 290 | 210 | 280 | 333 |
| Net financials | — | 0 | 0 | 10 | 5 |
| Profit before tax | 105 | 187 | 127 | 186 | 350 |
| Tax | −45 | −64 | −52 | −65 | −99 |
| Net profit | 60 | 123 | 75 | 121 | 251 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 179 | 1 528 | 1 570 | 1 815 | 1 884 |
| Equity | 403 | 526 | 351 | 372 | 302 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 115 | 117 | 131 | 132 | 162 |
| Total debt | 115 | 117 | 131 | 132 | 162 |
EBITDA margin
21.6%
This company
15.8%
Market median
+37% vs market
20212025
Equity ratio
16.0%
This company
38.2%
Market median
-58% vs market
20212025
Return on equity
83.2%
This company
18.4%
Market median
+352% vs market
20212025
Net profit margin
15.1%
This company
8.1%
Market median
+86% vs market
20212025
Asset turnover
0.88×
This company
1.12×
Market median
+21% vs market
20212025
Debt / equity
5.25×
This company
0.62×
Market median
-747% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GR Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ortofys Skane AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Glenn Rickard Johansson | Chief Executive Officer | 0 companies |
| Glenn Helge Jörgen Johansson | Deputy Board Member | 0 companies |
| Noor Johansson | Deputy Board Member | 0 companies |